Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Home
Safe Snack Guide
Peanut and Tree Nut Free Edition
Milk Free Edition
Sesame Free Edition
Gluten Free Edition
Custom Edition
Allergence
Coupons
About Us
SnackSafely.com Media Kit
SnackSafely.com Advertising Guide
Subscribe to our newsletter
Contact Us
Resources
FAQ
Partner Manufacturers
Tools for Schools
Coupons
Inspiring Food Allergy Bloggers and Authors
Search
Tag: skin patch
Company Receives $1.9 Million Grant to Advance Microneedle Patch Therapy for...
Dave Bloom
-
2021/08/02
Grant will allow Moonlight Therapeutics to complete pre-clinical activities and submit and IND to the FDA.
FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...
News Wire ~ 3rd Party Press Release
-
2020/02/22
Next step in the approval process for the therapy scheduled for May 15, 2020.
DBV Technologies Reports Positive Three-Year, Long Term Data from Phase III...
News Wire ~ 3rd Party Press Release
-
2020/01/09
Patients demonstrated durable, long-term clinical benefit with an additional two years of treatment.
Peanut Patch Phase III Enrollment Ends, Results Expected Toward End of...
Dave Bloom
-
2017/03/22
The study received higher-than-expected patient demand.
Study: EPIT (Skin Patch) Therapy Provides Sustained Protection Against Anaphylaxis
Dave Bloom
-
2016/06/13
The unique immune communication between skin and gastrointestinal tract can be used to generate long-lasting protection from food allergies.
Viaskin Peanut, Milk and Egg Patch Therapies: Promising News from the...
Dave Bloom
-
2016/03/07
We are cautiously optimistic that a safe, effective, easy to administer treatment for food allergy may be on the horizon.
Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II
Dave Bloom
-
2015/06/30
The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.
Peanut Patch Receives FDA's Breakthrough Therapy Designation
Dave Bloom
-
2015/04/09
The Viaskin Peanut patch received the BT designation after a positive Phase IIb trial.